Navigation Links
KellBenx Secures $2.5 Million Funding Round

NEW YORK, April 21, 2011 /PRNewswire/ -- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has secured an initial funding round of $2.5 million from four investors –  three biotechnology venture capital groups and one angel investor. The round will finance a clinical trial and laboratory testing of a new, minimally invasive blood test designed to identify risks to pregnancy ranging from pre-term birth to genetic conditions.

"We are delighted to have secured this round of funding and the support of our investors," said Hassan Bennani, MD., CEO of KellBenx. "The funds will be used to launch an IRB-approved clinical trial and build our Long Island laboratory to analyze the data we are producing. We are excited about the prospects of our technology and the company going forward."

"We are extremely pleased to partner with such an esteemed group of investors," said Leonard H. Kellner, President of KellBenx. "All of our investors bring tremendous energy, intellect and resources to this partnership, and we plan on leveraging their extensive networks to accelerate the adoption of KellBenx' revolutionary technologies."

About KellBenx

Founded in 2010, KellBenx, Inc. is a privately-held biotechnology company based in New York City. KellBenx is developing high value, innovative tests that leverage the ability to extract clinically relevant information from blood.  Our focus is to improve women's healthcare and one of our first tests is in the area of non-invasive prenatal diagnosis (NIPD) for genetic disorders. For more information, please call 631.643.2614 or visit

Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. KellBenx Secures Worldwide Agreement With Cedars-Sinai Medical Center for Biomarker Technology to Predict Premature Births
2. WNDM Secures Additional International Sales; $150 K in New Orders for 2011
3. BioNeutral Group Secures Three Initial Trial Orders for its Ogieneā„¢ Odor Neutralizer & Multi-Purpose Cleaner Product Line
4. ACT Secures Patent to Generate Embryonic Stem Cells Without Embryo Destruction
5. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
6. SeraCare Life Sciences Secures $20 Million Credit Facilities
7. Medizone International Secures $10,000,000 Funding Commitment
8. aTyr Pharma Secures $23M Financing From Top Tier Venture Investor
9. Omeros Secures $40 Million Committed Equity Financing Facility
10. SPO Medical Secures Agreement in Sleep Apnea Market
11. Biolaxy Secures IND Approval for Oral Insulin
Post Your Comments:
(Date:11/26/2015)... MUMBAI , November 26, 2015 ... --> Accutest Research ... accredited Contract Research Organization (CRO), has ... Chase Cancer Center - Temple Health ... ,     (Photo: ) ...
(Date:11/25/2015)... Md. , Nov. 25, 2015  PharmAthene, Inc. ... Directors has adopted a stockholder rights plan (Rights Plan) ... net operating loss carryforwards (NOLs) under Section 382 of ... --> PharmAthene,s use of its NOLs ... "ownership change" as defined in Section 382 of the ...
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... ... 25, 2015 , ... A long-standing partnership between the Academy ... been formalized with the signing of a Memorandum of Understanding. , AMA Executive ... Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA Headquarters ...
Breaking Biology Technology:
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... LA JOLLA, Calif. , Oct. 29, 2015 /PRNewswire-USNewswire/ ... released a new report titled, "DNA Synthesis and Biosecurity: ... how well the Department of Health and Human Services ... was issued in 2010. --> ... advances, but it also has the potential to pose ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
Breaking Biology News(10 mins):